Related Experiment Videos
Mutagenicity testing of pharmaceuticals: present status. Introduction
Archives of Toxicology
|November 1, 1980
Summary
An international conference in Paris discussed proposed guidelines for testing medicinal products for mutagenic potential. The meeting appraised discussions on these crucial drug safety protocols.
Area of Science:
- Pharmacology
- Toxicology
- Regulatory Science
Background:
- Proposed guidelines for mutagenic potential testing of medicinal products were issued in April 1979.
- The Committee on Proprietary Medicinal Products in Brussels developed these guidelines.
Purpose of the Study:
- To convene an international conference to discuss the proposed mutagenic potential testing guidelines.
- To appraise the discussions and outcomes of the conference.
Main Methods:
- An international conference was held in Paris from March 12-14, 1980.
- Discussions focused on the proposed guidelines for medicinal product mutagenicity testing.
Main Results:
- The conference provided a platform for international experts to deliberate on drug safety testing.
- Key discussions and expert opinions on mutagenic potential assessment were documented.
Conclusions:
- The conference facilitated a critical review of the proposed testing guidelines.
- The appraisal of discussions aimed to inform future regulatory actions on drug safety.